ERN BOND is an official partner of The World Orphan Drug Congress Europe.
This is the largest and most established event globally for orphan drugs and rare diseases.
Join over 2,000 attendees, gain insights from 250+ industry leaders, and connect with over 130 exhibitors as we bring together experts across the entire orphan drug lifecycle, discussing areas including regulatory affairs and policy to global pricing and cutting-edge gene therapies.
The attendees represent the most senior individuals across the industry, including leaders in R&D, gene therapy, rare diseases, precision/personalised medicine, genetic disorders, patient advocacy and engagement, associations in ATMPs, investors, regulatory affairs professions, governmental bodies, and more.
ERN BOND members are eligible for a free VIP pass: Apply here
Funded by the European Union



